These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23354816)

  • 1. In silico exploration of novel phytoligands against probable drug target of Clostridium tetani.
    Skariyachan S; Prakash N; Bharadwaj N
    Interdiscip Sci; 2012 Dec; 4(4):273-81. PubMed ID: 23354816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling on streptolysin-O of multidrug resistant Streptococcus pyogenes and computer aided screening and in vitro assay for novel herbal inhibitors.
    Skariyachan S; Narayan NS; Aggimath TS; Nagaraj S; Reddy MS; Narayanappa R
    Curr Comput Aided Drug Des; 2014 Mar; 10(1):59-74. PubMed ID: 24694051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain.
    Martin L; Cornille F; Coric P; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1998 Aug; 41(18):3450-60. PubMed ID: 9719598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-molecular-weight hemolysin of Clostridium tetani.
    Mitsui K; Mitsui N; Kobashi K; Hase J
    Infect Immun; 1982 Mar; 35(3):1086-90. PubMed ID: 7040245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and Antibiogram of Clostridium tetani from Clinically Diagnosed Tetanus Patients.
    Hanif H; Anjum A; Ali N; Jamal A; Imran M; Ahmad B; Ali MI
    Am J Trop Med Hyg; 2015 Oct; 93(4):752-6. PubMed ID: 26175031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insight from Computational Virtual Screening Depict the Binding Potential of Selected Phytotherapeutics Against Probable Drug Targets of Clostridium difficile.
    Kamath S; Skariyachan S
    Interdiscip Sci; 2018 Sep; 10(3):583-604. PubMed ID: 28217823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tetanolysin on platelets and lysosomes.
    Cox CB; Hardegree C; Fornwald R
    Infect Immun; 1974 Apr; 9(4):696-701. PubMed ID: 4595758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in the management of Clostridium tetani infection.
    Brook I
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):327-36. PubMed ID: 18588497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of tetanolysin-induced membrane damage: studies with black lipid membranes.
    Blumenthal R; Habig WH
    J Bacteriol; 1984 Jan; 157(1):321-3. PubMed ID: 6317656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The population structure of Clostridium tetani deduced from its pan-genome.
    Chapeton-Montes D; Plourde L; Bouchier C; Ma L; Diancourt L; Criscuolo A; Popoff MR; Brüggemann H
    Sci Rep; 2019 Aug; 9(1):11220. PubMed ID: 31375706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis of potential inhibitors of Ca(2+) activated K(+) channel blocker, Charybdotoxin-C from Leiurus quinquestriatus hebraeus through molecular docking and dynamics studies.
    Kumar RB; Priya BS; Suresh MX
    Indian J Pharmacol; 2015; 47(3):280-4. PubMed ID: 26069365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoenzimatic detection of the Clostridium tetani bacterial toxin: an alternative to mice bioassays].
    Chaves F; León G; Hernández-Chavarría F
    Rev Biol Trop; 2006 Jun; 54(2):253-6. PubMed ID: 18494295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medium composition on the production of tetanus toxin by Clostridium tetani.
    Fratelli F; Siquini TJ; Prado SM; Higashi HG; Converti A; de Carvalho JC
    Biotechnol Prog; 2005; 21(3):756-61. PubMed ID: 15932253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of scFv library of human antibodies against tetanus toxin.
    Nejad HR; Mehrabadi JF; Nourozi J; Mahdavi M
    Hum Antibodies; 2014; 23(1-2):21-6. PubMed ID: 25812699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of Clostridium tetani and laboratory diagnosis of tetanus].
    Smietańska K; Rokosz-Chudziak N; Rastawicki W
    Med Dosw Mikrobiol; 2013; 65(4):285-95. PubMed ID: 24730217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tetanus and Clostridium tetani--a brief review].
    Stock I
    Med Monatsschr Pharm; 2015 Feb; 38(2):57-60. PubMed ID: 26376540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pathogenomic analysis reveals a highly tetanus toxin-producing clade of
    Shitada C; Sekizuka T; Yamamoto A; Sakamoto C; Hashino M; Kuroda M; Takahashi M
    mSphere; 2023 Dec; 8(6):e0036923. PubMed ID: 38009947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Production of tetanolysin preparations and characteristics of their properties].
    Shabarov IA; Rumiantsev SN; Pospelov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):3-6. PubMed ID: 3898671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
    Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
    Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.